These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6313539)

  • 1. Conformational and biological properties of glucagon fragments containing residues 1-17 and 19-29.
    Carrey EA; Epand RM
    Int J Pept Protein Res; 1983 Sep; 22(3):362-70. PubMed ID: 6313539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of nonspecific hydrophobic interactions in the biological activity of N epsilon-acyl derivatives of glucagon. Studies of conformation, receptor binding, and adenylate cyclase activation.
    Carrey EA; Epand RM
    J Biol Chem; 1982 Sep; 257(18):10624-30. PubMed ID: 6286664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of specific trinitrophenylation of the lysine epsilon amino group of glucagon on receptor binding and adenylate cyclase activation.
    Liepnieks JJ; Epand RM
    Arch Biochem Biophys; 1983 Aug; 225(1):102-9. PubMed ID: 6311099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity studies of glucagon-like peptide-1.
    Adelhorst K; Hedegaard BB; Knudsen LB; Kirk O
    J Biol Chem; 1994 Mar; 269(9):6275-8. PubMed ID: 8119974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational and biological properties of di[delta-(5-nitro-2-pyrimidyl)ornithine 17,18]glucagon. Role of the arginine residues.
    Epand RM; Liepnieks JJ
    J Biol Chem; 1983 Jan; 258(1):203-7. PubMed ID: 6294099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-function relationships in glucagon. Re-evaluation of glucagon-(1-21).
    Frandsen EK; Thim L; Moody AJ; Markussen J
    J Biol Chem; 1985 Jun; 260(12):7581-4. PubMed ID: 2987259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-evaluation of glucagon1-6: the N-terminal hexapeptide of glucagon is not biologically active in the hepatic adenylate cyclase system.
    Pelton JT; Trivedi D; Hruby VJ
    Life Sci; 1983 Sep; 33(13):1307-14. PubMed ID: 6888179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semisynthetic D-His1,N epsilon-acetimidoglucagon: structure-function relationships.
    Mahrenholz AM; Flanders KC; Hoosein NM; Gurd FR; Gurd RS
    Arch Biochem Biophys; 1987 Sep; 257(2):379-86. PubMed ID: 2821912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon antagonists: contribution to binding and activity of the amino-terminal sequence 1-5, position 12, and the putative alpha-helical segment 19-27.
    Unson CG; Gurzenda EM; Iwasa K; Merrifield RB
    J Biol Chem; 1989 Jan; 264(2):789-94. PubMed ID: 2536024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor binding and adenylate cyclase activities of glucagon analogues modified in the N-terminal region.
    McKee RL; Pelton JT; Trivedi D; Johnson DG; Coy DH; Sueiras-Diaz J; Hruby VJ
    Biochemistry; 1986 Apr; 25(7):1650-6. PubMed ID: 3011069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of the C-terminal alpha-helical structure for glucagon's biological activity.
    Krstenansky JL; Zechel C; Trivedi D; Hruby VJ
    Int J Pept Protein Res; 1988 Dec; 32(6):468-75. PubMed ID: 2854536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A reassessment of structure-function relationships in glucagon. Glucagon1-21 is a full agonist.
    Wright DE; Hruby VJ; Rodbell M
    J Biol Chem; 1978 Sep; 253(18):6338-40. PubMed ID: 210180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic peptide antagonists of glucagon.
    Unson CG; Andreu D; Gurzenda EM; Merrifield RB
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4083-7. PubMed ID: 3035568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of 2-thioltryptophan-glucagon and (tryptophan-S-glucagon)2. Differences in binding to the glucagon receptor in the hepatic adenylate cyclase system.
    Wright DE; Rodbell M
    J Biol Chem; 1980 Nov; 255(22):10884-7. PubMed ID: 7430160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploitation of hormone-induced conformational changes to label selectively a component of rat liver plasma membranes.
    Storm DR; Chase RA
    J Biol Chem; 1975 Apr; 250(7):2539-45. PubMed ID: 164445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The glucagon receptor from liver can be functionally fused to caudate nucleus adenylate cyclase.
    Tolkovsky AM; Martin BR
    FEBS Lett; 1982 Dec; 150(2):337-42. PubMed ID: 6297980
    [No Abstract]   [Full Text] [Related]  

  • 17. Acetylglucagon: preparation and characterization.
    Desbuguois B
    Eur J Biochem; 1975 Dec; 60(2):335-47. PubMed ID: 1270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photoaffinity labeling of the glucagon receptor with a new glucagon analog.
    Wright DE; Horuk R; Rodbell M
    Eur J Biochem; 1984 May; 141(1):63-7. PubMed ID: 6327311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reaction of glucagon with its receptor: evidence for discrete regions of activity and binding in the glucagon molecule.
    Rodbell M; Birnbaumer L; Pohl SL; Sundby F
    Proc Natl Acad Sci U S A; 1971 May; 68(5):909-13. PubMed ID: 5280527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon1-6 binds to the glucagon receptor and activates hepatic adenylate cyclase.
    Wright DE; Rodbell M
    J Biol Chem; 1979 Jan; 254(2):268-9. PubMed ID: 216670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.